A first-in-human trial testing a novel allogeneic synthetic TCR and antigen receptor (STAR) T cell therapy has shown encouraging early results in patients with severe, treatment-resistant systemic lupus erythematosus (SLE). The post STAR T, An Allogeneic CAR T Alternative, Is Effective in Lupus Patients appeared first on Inside Precision Medicine.
